Algal fucoidan, unlike heparin, has thrombolytic activity in a murine arterial thrombosis model

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 5, 2012, Pages 359-366

  Min, Soon Ki ^a   Han, Sung Mi ^b   Kim, Hong Tae ^b   Kwon, Oh Choon ^a   Lee, Sub ^a   Kim, Jong Ki ^a  

^a Catholic University of Daegu   (South Korea)

^b Department of Anatomy ^*  (South Korea)

Author keywords

algal fucoidan; reocclusion; reperfusion; stimulatory effect; thrombin inhibitor; thrombolysis

Indexed keywords

ANTICOAGULANT AGENT; FUCOIDIN; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; FUCUS; FUCUS VESICULOSUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; UNDARIA; UNDARIA PINNATIFIDA SPOROPHYLLS;

ANIMALS; CAROTID ARTERIES; CHLORIDES; CORONARY THROMBOSIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FERRIC COMPOUNDS; FIBRINOLYTIC AGENTS; HEPARIN; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED BALB C; POLYSACCHARIDES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; UNDARIA;

EID: 84863315385     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283518815     Document Type: Article

References (31)

1. Gold HK, Leinbach RC, Garabedian HD, Yasuda T, Johns JA, Grossbard EB, et al. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation 1986; 73:347-353.
2. Verstraete M, Arnold AER, Brower RW, Collen D, de Bono DP, De Zwaan C, et al. Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate. Am J Cardiol 1987; 60:231-237. (Pubitemid 17133049)
3. Hotchkiss KA, Chesterman CN, Hogg PJ. Inhibition of heparin activity in plasma by soluble fibrin: evidence for ternary thrombin-fibrin-heparin complex formation. Blood 1994; 84:498-503. (Pubitemid 24215950)
4. Hogg PJ, Jackson C. Heparin promotes the binding of thrombin to fibrin: polymer quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex. J Biol Chem 1990; 265:241-247. (Pubitemid 20032335)
5. Wang W, Hendriks DF, Scharpe SS. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J Biol Chem 1994; 269:15937-15944. (Pubitemid 24202197)
6. Jang I, Gold H, Ziskind A, Fallon J, Holt R, Leinbach R, et al. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. Circulation 1989; 79:920-928. (Pubitemid 19100552)
7. Pereira MS, Mulloy B, Mourão PAS. Structure and anticoagulant activity of sulfated fucans. J Biol Chem 1999; 274:7656-7667.
8. Nardella A, Chaubet F, Boisson-Vidal C, Blondin C, Durand P, Josefonvicz J. Anticoagulant low molecular weight fucans produced by radical process and ion exchange chromatography of high molecular weight fucans extracted from the brown seaweed Ascophyllum nodosum. Carbohydr Res 1996; 289:201-208. (Pubitemid 26295459)
9. Mauray S, Sternberg C, Theveniaux J, Millet J, Sinquin C, Tapon-Bretaudiere J, Fischer AM. Venous antithrombotic and anticoagulant activities of a fucoidan fraction. Thromb Haemost 1995; 74:1280-1285.
10. Durand E, Helley D, Al Haj Zen A, Dujols C, Bruneval P, Colliec-Jouault S, Fischer AM. Effect of low molecular weight fucoidan and low molecular weight heparin in a rabbit model of arterial thrombosis. J Vascul Res 2008; 45:529-537.
11. Colliec-Jouault S, Millet J, Helley D, Sinquin C, Fischer AM. Effect of lowmolecular-weight fucoidan on experimental arterial thrombosis in the rabbit and rat. Thromb Haemost 2003; 1:1114-1115.
12. Thorlacius H, Vollmar B, Seyfert UT, Vestweber D, Menger MD. The polysaccharide fucoidan inhibits microvascular thrombus formation independently from P-and L-selectin function in vivo. Eur J Clin Invest 2000; 30:804-810.
13. Soeda S, Sakaguchi S, Shimeno H, Nagamatsu A. Fibrinolytic and anticoagulant activities of high sulfated fucoidan. Biochem Pharmacol 1992; 43:1853-1858.
14. Doctor VM, Hill C, Jackson GJ. Effect of fucoidan during activation of human plasminogen. Thromb Res 1995; 79:237-247.
15. Minx R, Doctor VM. Interaction of fucoidan with proteases and inhibitors of coagulation and fibrinolysis. Thromb Res 1997; 87:419-429. (Pubitemid 27431625)
16. Nishino T, Yamauchi T, Horie M, Nagumo T, Suzuki H. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA. Thromb Res 2000; 99:623-634. (Pubitemid 30642744)
17. Jeong ES, Yoon YH, Kim JK. Contrasting correlation in the inhibition of response of ADP-induced platelet aggregation and the anticoagulant activities of algal fucoidans derived from Eisenia bicyclis and Undaria pinnatifida sporophylls. Fish Aqua Sci 2009; 12:194-202.
18. Koo JK, Jo KS, Do JR, Woo SJ. Isolation and purification of fucoidans from Laminaria religiosa and Undaria pinnatifida in Korea. J Kor Fish Soc 1995; 28:227-236.
19. Nagasawa K, Uchiyama H, Sato N, Hatano A. Chemical change involved in the oxidative-redutive depolymerization of heparin. Carbohydr Res 1992; 236:165-180. (Pubitemid 23013605)
20. Cumashi A, Ushakova NA, Preobrazhenskaya ME, D'Incecco A, Piccoli A, Totani L, et al. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007; 17:541-552. (Pubitemid 47049941)
21. Lang DS, Williams T, Phillips A, Doctor VM. Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride. Eur J Drug Metab Pharmacokinet 2004; 29:269-275. (Pubitemid 40248967)
22. Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin. J Biol Chem 1982; 257:2912-2919. (Pubitemid 12118804)
23. Emeis J. Tissue-type plasminogen activator: physiological and clinical aspects. Boca Raton, Florida: CRC Press; 1988.
24. Emeis JJ. Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Ann N Y Acad Sci 1992; 667:249-258. (Pubitemid 23061588)
25. Min S-K, Kwon O-H, Lee S, Park K-H, Kim J-K. An antithrombotic fucoidan, unlike heparin, does not prolong bleeding time in a murine arterial thrombosis model: a comparative study of Undaria pinnatifida sporophylls and Fucus vesiculosus. Phytotherapy Res 2011. doi: 10.1002/ptr. 3628.
26. Koo J-K, Choi Y-S, Kwak J-K. Blood-anticoagulant activity of fucoidans from Sporophylls of Undaria pinnatifida, Laminaria religiosa, Hizikia fusiforme and Sargassum fulvellum in Korea. J Kor Fish Soc 2001; 34:515-520.
27. Dürig J, Bruhn T, Zurborn K-H, Gutensohn K, Bruhn HD, Béress L. Anticoagulant fucoidans from Fucus vesiculosus induced platelet activation in vitro. Thrombosis Res 1997; 85:479-491. (Pubitemid 27209939)
28. Booth NA, Simpson AJ, Croll A, Bennet B, MacGregor IR. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 1988; 70:327-333. (Pubitemid 18265252)
29. Potter van Loon BJ, Rijiken DC, Brommer EJP, Van der Maas APC. The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility. Thromb Haemost 1992; 67:101-105.
30. Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 1999; 99:3050-3055. (Pubitemid 29270436)
31. Zhu Z, Zhang Q, Chen L, Ren S, Xu P, Tang Y, Luo D. Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet aggregation. Thromb Res 2010; 125:419-426.